The Objectives of This Study Are Study of the Reactogenicity, Safety and Immunogenicity of Flu-M Inactivated Split Influenza Vaccine in Volunteers Aged 18-60 Years
Clinical trial NCT05126979 · COMPLETED
Trial details
- NCT number
- NCT05126979
- Sponsor
- St. Petersburg Research Institute of Vaccines and Sera
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-09
- Primary completion
- 2016-04-25
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.